Gene-Targeted Approach to Tissue Regeneration
Vira Regen delivers noninvasive, gene-targeted bioelectric stimulation directly at the site of injury to precisely and dynamically modulate therapeutic gene expression on demand—amplifying the body’s natural healing response.
Unlike traditional stimulation technologies that rely on broad, nonspecific signals, Vira Regen’s platform operates with molecular precision—targeting the genetic drivers of repair directly rather than indiscriminately stimulating tissue.
By integrating transcriptomic profiling, bioinformatics, and precision-engineered signal design, we selectively activate regenerative pathways that translate into meaningful, functional tissue repair and increased efficacy.
Our first proof-of-concept is in bone regeneration, where Vira Regen has received approximately $2M in nondilutive funding from the U.S. Department of Defense to develop a novel bone growth stimulator based off of this core technology for accelerated limb fracture repair, addressing critical needs across both military and civilian healthcare.
Bone Remodeling
Our first therapeutic application focuses on accelerating bone remodeling and repair. Through gene-targeted bioelectrical stimulation, Vira Regen’s platform activates osteogenic signaling pathways, key regulators of osteoblast differentiation and mineralized callus formation.
Our in-vitro studies have shown we can selectively modulate OPG and TGFB-1, two key genes in the osteogenic cascade.
In pre-clinical studies this targeted modulation has demonstrated enhanced bone density, faster union, and more complete structural recovery compared to traditional, non-specific methods.
A New Approach to Bioelectronic Medicine
Bioelectric therapeutics and stimulation devices for targeted regeneration. Creating a new class of bioelectric medicine that modulates genes to unlock the body’s regenerative potential
